EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
91 hedge funds and large institutions have $54.8M invested in Eagle Pharmaceuticals, Inc. in 2024 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 38 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
91
Holders Change
-13
Holders Change %
-12.5%
% of All Funds
1.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
24
Reduced
38
Closed
29
Calls
$16K
Puts
$202K
Net Calls
-$186K
Net Calls Change
-$650K
Top Buyers
Top Sellers
1 |
Janus Henderson Group
London,
United Kingdom
|
-$4.06M |
2 |
BIP
Brandes Investment Partners
La Jolla,
California
|
-$3.9M |
3 |
Millennium Management
New York
|
-$1.39M |
4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.23M |
5 |
Morgan Stanley
New York
|
-$1.14M |